一个真实世界的Everolimus不成比例分析:FDA不良事件报告系统的公共版本的数据挖掘
Bin Zhao1,2, Yumei Fu3, Shichao Cui4
1Xiamen Health and Medical Big Data Center, Xiamen, China.
Frontiers in pharmacology
|March 27, 2024
概括
这项研究使用FAERS数据确定了与Everolimus相关的常见和意外不良事件. 这些发现加强了对Everolimus药物安全性的监测和管理.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 药品安全 药品安全
背景情况:
- 作为一种mTOR抑制剂的Everolimus可以治疗各种瘤.
- 不良事件 (AE) 需要进行彻底评估.
- 法尔斯的数据挖掘为药物安全提供了洞察力.
研究的目的:
- 评估与Everolimus相关的不良事件 (AE).
- 通过数据挖掘来识别常见和意想不到的AE.
- 为了提高Everolimus的临床药物安全性.
主要方法:
- 利用美国食品和药物管理局不良事件报告系统 (FAERS) 数据 (2009-2022年).
- 在AE信号检测中使用不成比例分析 (ROR,PRR,BCNN,EGBM).
- 使用医学监管活动词典 (MedDRA) 进行分类的AE.
主要成果:
- 在24个器官系统类别中分析了24575份Everolimus AE报告.
- 识别了常见的显著副作用:新生体,生殖/乳腺疾病,口炎,肺炎,胰岛素分泌受损.
- 发现了意想不到的重大副作用:胆管缺血症,血管纤维瘤,结核性硬化综合体.
结论:
- 提供了对Everolimus药物不良反应监测和管理的新见解.
- 突出严重和意想不到的AE信号需要临床关注.
- 旨在提高Everolimus治疗期间的药物安全性.
相关概念视频
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Nonlinear Pharmacokinetics: Overview
364
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
364


